Velarion Records
Free. Unsubscribe any time.

HALOZYME THERAPEUTICS, INC. (HALO)

HALOZYME THERAPEUTICS, INC. filed 34 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 140 transactions and 842,050 shares. None carries the SEC's AFF10B5ONE flag; all 34 name a plan in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in HALOZYME THERAPEUTICS, INC. 140

Adoption dates in HALOZYME THERAPEUTICS, INC. 2

Results prints in HALOZYME THERAPEUTICS, INC. 9

Trades before a print in HALOZYME THERAPEUTICS, INC. 4

Interval to HALOZYME THERAPEUTICS, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates HALOZYME THERAPEUTICS, INC. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on September 18, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.